Even if a website looks professional, there may be no reliable way to check the source, strength, sterility, storage conditions or contents of the product
After treatment initiation with liraglutide 3.0 mg, it is recommended that, if a patient has not lost at least 4% of their baseline body weight after 16 weeks, the treatment should be discontinued because it is unlikely that significant weight loss will be achieved with the medication after this time point [21]
The technology is promising, but it is still in the research phase
There are also many concerns about the long-term effects of GLP-1s, especially for non-diabetic users
The majority of AstraZenecas growth came from Farxiga (dapagliflozin), a SGLT2 inhibitor indicated for heart failure and kidney disease